Choose based on side effect profile and lifestyle
Kayser-Fleischer rings and sunflower cataract Your doctor will also check for Kayser-Fleischer (K-F) rings and sunflower cataract in the eyes
Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1/VEGF axis
EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity
GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months